Ranibizumab joins laser surgery as diabetic macular edema treatment

The FDA has approved once-monthly, 0.3-mg ranibizumab injection (Lucentis, Genentech) for treatment of diabetic macular edema (DME), making it the first and only drug approved by the agency for the condition. The standard of care for DME for the past 25 years has been laser surgery.

Full Story →